These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 4912)

  • 1. [Pilot study of SCH-12679 in profoundly mentally retarded patients with severe behavior disorders].
    Albert JM; Langlois Y; Gravel L
    Union Med Can; 1975 Jun; 104(6):904-9. PubMed ID: 4912
    [No Abstract]   [Full Text] [Related]  

  • 2. Pilot study with RO 5-4556 in emotionally disturbed retarded children.
    Ucer E
    Curr Ther Res Clin Exp; 1968 Apr; 10(4):187-95. PubMed ID: 4967223
    [No Abstract]   [Full Text] [Related]  

  • 3. Haloperidol for control of severe emotional reactions in mentally retarded patients.
    Grabowski SW
    Dis Nerv Syst; 1973; 34(6):315-7. PubMed ID: 4782288
    [No Abstract]   [Full Text] [Related]  

  • 4. [Apropos of the use of diazepam (Valium) in the treatment of behavior disorders in profoundly retarded children. "Utilization in 32 children aged 9 to 14 years for 1 year"].
    Ledoux G; Serret J; Reynes M
    Ann Med Psychol (Paris); 1968 Feb; 1(2):285-92. PubMed ID: 5661587
    [No Abstract]   [Full Text] [Related]  

  • 5. The treatment of behavior disorders in idiocy and imbecility with clozapine.
    Vyncke J
    Pharmakopsychiatr Neuropsychopharmakol; 1974 Sep; 7(5):225-9. PubMed ID: 4614278
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experiences with psychopharmaceutic agents in mentally retarded children].
    Dosen A
    Tijdschr Kindergeneeskd; 1982 Feb; 50(1):10-9. PubMed ID: 6124053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sulpiride versus chlorpromazine and placebo in the treatment of restless mentally subnormal patients--a double-blind cross-over study.
    Väisänen K; Kainulainen P; Paavilainen MT; Viukari M
    Curr Ther Res Clin Exp; 1975 Feb; 17(2):202-5. PubMed ID: 803431
    [No Abstract]   [Full Text] [Related]  

  • 8. [Trial of dipotassium chlorazepate in child psychiatry].
    Launay C; Houzel D
    Rev Neuropsychiatr Infant; 1972 May; 20(5):491-5. PubMed ID: 5081843
    [No Abstract]   [Full Text] [Related]  

  • 9. [Behavior disorders of the active type in mentally retarded patients].
    Mitjavile I
    Soins Psychiatr; 1984 Dec; (50):13-5. PubMed ID: 6570579
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of lorazepam on hyperactivity in ratarded children.
    Walters A; Singh N; Beale IL
    N Z Med J; 1977 Nov; 86(600):473-5. PubMed ID: 24194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Preliminary notes on personality disorders in profoundly retarded children].
    Fau R; Château R; Boucharlat J
    Ann Med Psychol (Paris); 1968 Feb; 1(2):262-8. PubMed ID: 5651949
    [No Abstract]   [Full Text] [Related]  

  • 12. A double-blind study comparing haloperidol with thioridazine in emotionally disturbed, mentally retarded children.
    Ucer E; Kreger KC
    Curr Ther Res Clin Exp; 1969 May; 11(5):278-83. PubMed ID: 4977399
    [No Abstract]   [Full Text] [Related]  

  • 13. [Evaluation of a new benzodiazepine preparation in the treatment of cenesthopathias and behavior disorders in children].
    Brogi G; Aimi W
    Minerva Pediatr; 1975 Jun; 27(20):1151-61. PubMed ID: 237231
    [No Abstract]   [Full Text] [Related]  

  • 14. Drugs for mentally handicapped children.
    Br Med J; 1976 Apr; 1(6015):923-4. PubMed ID: 1268489
    [No Abstract]   [Full Text] [Related]  

  • 15. Pipamperone (Dipiperon) in the treatment of behaviour disorders. A large-scale multicentre evaluation.
    Deberdt R
    Acta Psychiatr Belg; 1976; 76(1):157-66. PubMed ID: 970185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Influence of relaxation on the behavior of mentally retarded children. (Introduction of muscular relaxation sessions in an educational program for 2 mentally retarded children with neurologic manifestations)].
    Destrooper J; Vayer P
    Rev Med Psychosom Psychol Med; 1972; 14(1):69-82. PubMed ID: 5068489
    [No Abstract]   [Full Text] [Related]  

  • 17. Pilot open label study with alprazolam (U31, 889) in outpatients with neurotic depression.
    Fabre LF
    Curr Ther Res Clin Exp; 1976 Jun; 19(6):661-8. PubMed ID: 6216
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical study on the use of SB 5833 (Camazepam) in general medicine].
    Melloni GF; Saurgnani E; Ghirardi P
    Minerva Med; 1974 Aug; 65(58):3063-70. PubMed ID: 4152651
    [No Abstract]   [Full Text] [Related]  

  • 19. Classifying mental retardation and specific strength and deficit areas in severe and profoundly mentally retarded persons with the MESSIER.
    Matson JL; Dixon DR; Matson ML; Logan JR
    Res Dev Disabil; 2005; 26(1):41-5. PubMed ID: 15590236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Characteristics of mental disorders in psychiatric patients with mental retardation--preliminary communication].
    Bobińska K; Florkowski A; Gałecki P
    Pol Merkur Lekarski; 2008; 25 Suppl 1():8-12. PubMed ID: 19025040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.